Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin

Abstract:

Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were formed. Multiple optimisation steps produced DMPs which caused tumour cell death. Treatment of mice bearing tumours with DMP decreased tumour growth and spread, with no visible side-effects. There are plans to evaluate this delivery vehicle more closely towards clinical development and testing.

• Periodical: Advanced Materials Research (Volumes 93-94)
• Pages: 703-706
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.93-94.703
• Online since: January 2010
• Authors: Mei Lin Tan, Peter F.M. Choong, Crispin R. Dass
• Keywords: Cancer, Chitosan (CS), Complex, Delivery, Doxorubicin

References

[1] Tan ML, Choong PF, Dass CR. Cancer, chitosan nanoparticles and catalytic nucleic acids. J Pharm Pharmacol 2009; 61(1): 3-12.

[2] Tan ML, Choong PF, Dass CR. Doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol. 2009; 61(2): 131-42.

[3] Kremer LC, van Dalen EC, Offringa M, Voute PA. Frequency and risk factors of anthracyclineinduced clinical heart failure in children: a systematic review. Ann Oncol 2002; 13(4): 503-12.

DOI: 10.1093/annonc/mdf118

[4] Longhi A, Ferrari S, Bacci G, Specchia S. Long-term follow-up of patients with doxorubicininduced cardiac toxicity after chemotherapy for osteosarcoma. Anticancer Drugs 2007; 18(6): 737-44.

DOI: 10.1097/cad.0b013e32803d36fe

[5] Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006; 32(6): 423-36.

DOI: 10.1016/j.ctrv.2006.05.005

[6] Mitra S, Gaur U, Ghosh PC, Maitra AN. Tumour targeted delivery of encapsulated dextrandoxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 2001; 74(13): 317-23.

DOI: 10.1016/s0168-3659(01)00342-x

[7] Dass CR, Ek ET, Contreras KG, Choong PF. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis. 2006; 23(7-8): 367-80.

DOI: 10.1007/s10585-006-9046-6

[8] Berlin O, Samid D, Donthineni-Rao R, Akeson W, Amiel D, Woods VL Jr. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res. 1993 15; 53(20): 4890-5.